Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 18/20 | 0.65 |
| ▸ | CSNK2A2 | P19784 | 17/20 | 0.65 |
| ▸ | CSNK2B | P67870 | 14/20 | 0.65 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.55 |
| ▸ | CSNK2A3 | Q8NEV1 | 4/20 | 0.55 |
| ▸ | BRD4 | O60885 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | LATS1 | O95835 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25370767 | 1.00 | CSNK2A1 (0.65) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL25371719 | 0.93 | CSNK2A1 (0.56) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL26049255 | 0.93 | CSNK2A2 (0.56) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL30803559 | 0.93 | CSNK2A1 (0.55) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL30803489 | 0.92 | CSNK2A1 (0.65) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL27320168 | 0.92 | CSNK2A1 (0.65) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL27319994 | 0.90 | CSNK2A1 (0.67) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL30803507 | 0.87 | CSNK2A1 (0.59) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL25371343 | 0.86 | CSNK2A2 (0.49) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 | |
| SCHEMBL29900367 | 0.86 | CSNK2A2 (0.49) | CSNK2A1CSNK2A2CSNK2BHDAC1CSNK2A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584265-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052690-A1 | NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |
| EP-4301752-A1 | BENZO[C][2,6]NAPHTHYRIDINE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USES THEREOF | Cambridge Enterprise Limited (GB) | 2024-01-10 | — | — | EP | disclosed |
| WO-2022185041-A1 | BENZO[C][2,6]NAPHTHYRIDINE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USES THEREOF | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2022-09-09 | — | — | WO | disclosed |